- Home
- GORV vs CLNN Comparison
GORV vs CLNN Comparison
Compare GORV & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- CLNN
- Stock Information
- Founded
- GORV 1976
- CLNN 2012
- Country
- GORV United States
- CLNN United States
- Employees
- GORV N/A
- CLNN N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- GORV Consumer Discretionary
- CLNN Health Care
- Exchange
- GORV Nasdaq
- CLNN Nasdaq
- Market Cap
- GORV 25.3M
- CLNN 23.1M
- IPO Year
- GORV 2015
- CLNN N/A
- Fundamental
- Price
- GORV $4.32
- CLNN $3.71
- Analyst Decision
- GORV Hold
- CLNN Strong Buy
- Analyst Count
- GORV 2
- CLNN 5
- Target Price
- GORV $60.00
- CLNN $40.00
- AVG Volume (30 Days)
- GORV 38.4K
- CLNN 70.5K
- Earning Date
- GORV 08-19-2025
- CLNN 08-19-2025
- Dividend Yield
- GORV N/A
- CLNN N/A
- EPS Growth
- GORV N/A
- CLNN N/A
- EPS
- GORV N/A
- CLNN N/A
- Revenue
- GORV $767,257,000.00
- CLNN $350,000.00
- Revenue This Year
- GORV $15.65
- CLNN N/A
- Revenue Next Year
- GORV $20.54
- CLNN $1,753.57
- P/E Ratio
- GORV N/A
- CLNN N/A
- Revenue Growth
- GORV N/A
- CLNN N/A
- 52 Week Low
- GORV $3.83
- CLNN $2.28
- 52 Week High
- GORV $77.07
- CLNN $6.90
- Technical
- Relative Strength Index (RSI)
- GORV 28.97
- CLNN 56.54
- Support Level
- GORV $3.83
- CLNN $3.30
- Resistance Level
- GORV $5.49
- CLNN $3.93
- Average True Range (ATR)
- GORV 0.50
- CLNN 0.21
- MACD
- GORV -0.18
- CLNN 0.03
- Stochastic Oscillator
- GORV 5.06
- CLNN 88.24
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.